Tvardi Therapeutics Balance Sheet (2013-2025) | TVRD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	22.52M	22.34M	22.99M	13.45M	21.36M	46.72M	42.81M	63.74M	47.39M	58.25M	62.88M	51.77M	47.00M	49.24M	37.06M	31.61M	34.22M	20.65M	21.40M	20.73M
Short-term Investments (Quarter)	149.06M	132.84M	121.20M	153.58M	119.75M	110.79M	112.81M	81.66M	0.41M	36.44M	15.67M	48.98M	22.78M	7.38M	1.50M			20.30M	15.00M	10.10M
Cash & Current Investments (Quarter)	171.58M	155.18M	144.19M	167.03M	141.11M	157.51M	155.61M	145.40M	47.80M	94.69M	78.54M	100.76M	69.77M	56.62M	38.56M	31.61M	34.22M	40.95M	36.40M	30.83M
Receivables - Net (Quarter)	1.90M		20.03M					3.26M			3.35M	2.77M	1.72M	0.36M	0.43M	0.41M	1.23M
Receivables - Other (Quarter)	2.24M	0.30M	20.35M	0.46M	0.44M	0.47M	0.45M	0.49M	6.07M	0.42M	1.68M	0.56M	0.51M	0.76M	0.10M	4.09M	1.01M
Receivables (Quarter)	4.14M	0.30M	40.38M	0.46M				3.75M			5.03M	3.32M	2.22M	1.12M	0.53M	4.50M	2.24M
Raw Materials (Quarter)				0.93M	1.09M	1.82M	1.83M
Work In Process (Quarter)				1.66M	0.81M	0.64M	0.00M
Finished Goods (Quarter)						1.00M
Inventory (Quarter)				2.58M	1.91M	3.46M	1.83M	2.42M	3.52M	3.42M	3.27M	3.35M	2.79M	1.64M	2.14M	0.90M	2.42M
Prepaid Assets (Quarter)	13.02M	8.29M	6.26M	0.67M	0.81M	0.83M	18.56M	16.27M	17.20M	1.01M	0.66M	0.42M	0.47M	0.30M	0.17M	0.05M	0.11M	0.53M	0.23M	0.19M
Current Assets (Quarter)	188.35M	164.47M	171.50M	173.29M	151.76M	176.17M	186.78M	168.91M	142.66M	124.74M	100.60M	116.16M	81.22M	63.86M	47.91M	31.69M		43.13M	38.44M	31.54M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.78M	0.72M	0.65M	0.63M	0.61M	0.55M	0.49M	0.43M	0.37M	0.31M	1.38M	3.32M	3.55M	3.49M	3.42M	0.08M		0.07M	0.06M	0.05M
Long-Term Investments (Quarter)	56.73M	52.22M	49.22M	69.75M	68.46M	47.17M	23.92M	11.35M	9.07M	7.05M	4.75M
Intangibles (Quarter)																0.39M		0.35M	0.34M	0.32M
Goodwill & Intangibles (Quarter)																0.39M		0.35M	0.34M	0.32M
Other Non-Current Assets (Quarter)	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M			1.50M	1.50M	1.50M	1.50M	1.50M		2.81M		0.02M	0.02M	0.02M
Non-Current Assets (Quarter)	61.88M	56.98M	53.59M	73.77M	72.10M	50.41M	26.73M	13.33M	10.62M	9.65M	14.73M	9.69M	8.87M	8.64M	3.42M	3.51M		0.62M	0.58M	0.54M
Assets (Quarter)	250.23M	221.45M	225.09M	247.06M	223.87M	226.57M	213.51M	182.24M	153.28M	134.39M	115.34M	125.84M	90.10M	72.50M	51.33M	35.20M	38.95M	43.75M	39.02M	32.07M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	14.88M	13.49M	13.81M	15.86M	5.59M	19.33M	26.32M	9.60M	15.22M	24.48M	22.38M	11.58M	14.88M	6.75M	6.62M	2.19M	0.00M	2.42M	4.08M	3.22M
Payables (Quarter)	14.88M	13.49M	13.81M	15.86M	5.59M	19.33M	26.32M	9.60M	15.22M	24.48M	22.38M	11.58M	14.88M	6.75M	6.62M	2.19M	0.00M	2.42M	4.08M	3.22M
Accumulated Expenses (Quarter)	2.34M	3.15M	4.12M	4.96M	2.41M	3.35M	4.23M	5.22M	2.95M	4.20M	5.37M	6.52M	2.06M	1.21M	1.17M	1.14M	0.61M	0.74M	1.01M	1.30M
Other Accumulated Expenses (Quarter)																0.01M		0.45M	0.45M	0.32M
Current Leases (Quarter)	1.64M	1.68M	1.72M	1.75M	1.79M	1.83M	1.88M	1.92M	1.46M	0.98M	0.50M		0.22M	0.17M	3.42M	0.10M		0.11M	0.11M	0.12M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	16.52M	15.17M	15.53M	17.62M	18.30M	21.17M	28.19M	23.46M	16.68M	25.46M	22.88M	25.59M	15.10M	13.90M	10.04M	10.37M	1.20M	10.68M	11.04M	11.04M
Non-Current Liabilities
Convertible Debt (Quarter)																30.26M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)												85.50M	85.50M	85.50M	85.50M	85.50M	85.50M
Operating Leases (Quarter)	3.25M	2.82M	2.37M	1.92M	1.46M	0.98M	0.50M				6.82M	6.09M	6.83M	7.32M		0.20M		0.14M	0.12M	0.09M
Other Non-Current Liabilities (Quarter)												37.08M	38.38M	39.68M	40.58M	44.45M	45.82M
Total Non-Current Liabilities (Quarter)												31.68M	21.92M	21.22M	10.04M	-3.62M	1.20M
Total Liabilities (Quarter)	19.77M	17.99M	17.90M	19.53M	19.75M	22.15M	28.69M	23.46M	16.68M	25.46M	29.70M	68.76M	60.30M	60.90M	50.62M	40.83M	47.02M	10.82M	11.15M	11.13M
Shareholder's Equity
Common Equity (Quarter)	230.46M	203.47M	207.19M	227.52M	204.12M	204.42M	184.82M	158.78M	136.60M	108.93M	85.64M	-62.06M	-66.17M	-73.07M	-78.50M	-91.13M	-100.62M	32.93M	27.87M	20.95M
Shareholder's Equity (Quarter)	230.46M	203.47M	207.19M	227.52M	204.12M	204.42M	184.82M	158.78M	136.60M	108.93M	85.64M	-62.06M	-66.17M	-73.07M	-78.50M	-91.13M	-100.62M	32.93M	27.87M	20.95M
Liabilities and Shareholders Equity (Quarter)	250.23M	221.45M	225.09M	247.06M	223.87M	226.57M	213.51M	182.24M	153.28M	134.39M	115.34M	125.84M	90.10M	72.50M	51.33M	35.20M	38.95M	43.75M	39.02M	32.07M
Retained Earnings (Quarter)	0.01M	-446.36M	0.00M	-480.76M	-508.51M	-512.71M	-535.89M	-566.23M	-592.90M	-0.73M	-652.41M	-0.26M	-715.44M	-735.46M	-747.93M	-92.24M	-760.52M	-97.65M	-103.20M	0.01M
Treasury Shares (Quarter)	0.40M	0.41M	0.37M	0.58M	0.74M	0.65M	0.64M	0.03M	0.70M	0.79M	0.78M	0.05M	0.01M	0.98M	0.97M	0.03M	0.03M

Research Tools

Tvardi Therapeutics Balance Sheet (2013-2025) | TVRD

Create an account

Sign In

Reset Password